ClinicalTrials.gg
RecruitingNCT06908538VANISHUpdated Nov 6, 2026

Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain

An observational study in Amputation, Amputation of Lower Limb and Amputation of Upper Limb, sponsored by AtriCure, Inc.. Recruiting at 9 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by AtriCure, Inc. · Observational

How we know

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 7 months later.
Updated Nov 6, 20263 sites addedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
2,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 64 studies in Amputation, Traumatic with a site in United States — 12 open to participants now, 15 under way, 1 of them phase 3. Amputation, Traumatic · United States.

Planned enrollment
2nd of 11
2,000 · median 60
Started
2025
with 2 others
Observational
11 of 64
2 open now
Primary completion
2035-04
later than 12 of 14 live
Registered
61st of 64
by date

Among the 64 studies in Amputation, Traumatic with a site in United States, this one is the 2nd largest by planned enrollment of the 11 observational ones that give a count, is one of 3 that started in 2025, is one of 11 observational ones, reaches primary completion later than 12 of the 14 other live ones, and was the 61st registered.

Amputation, Traumatic

112 studies on the registry are indexed under Amputation, Traumatic; 24 are open to participants now.

Browse Amputation, Traumatic studies →

Open to participants now

12 of the 64 studies in Amputation, Traumatic with a site in United States are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 18 Amputation, Traumatic studies recruiting now, 6 (33%) set no upper age limit and 9 (50%) stop at 75 or younger; 1 takes children under 18; none take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 64 studies in Amputation, Traumatic with a site in United States, or all of them as a file.
02

Study summary

The goal of this Registry is to see how the device is used when freezing nerves during an amputation procedure.

03

Conditions studied

  • Amputation
  • Amputation of Lower Limb
  • Amputation of Upper Limb
  • Amputation, Limb Loss
  • Amputation, Traumatic/Surgery
  • Cryo Analgesia

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects who have or will have an amputation procedure.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who have or will have an amputation procedure;
  • Patients who are willing and capable of providing ;
  • Patients whose age is 18 years or above, or of legal age to give informed consent specific to state and national law.

Exclusion criteria

Exclusion Criteria:

  • Women of who are, or plan to become, pregnant during the time of the study;
  • Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
2,000 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • Subjects who have or will have an amputation procedure.

    The primary objective of this Registry is to capture real-world safety and performance data on AtriCure devices used to cryoablate nerves during an extremity amputation procedure.

    Device: cryoablation

Interventions

  • Devicecryoablation

    Cryoanalgesia, also known as Cryoablation, Cryoneurolysis, or Cryonerve Block, has been used for decades to treat chronic pain and has recently been employed for the management of Phantom Limb Pain. Cryoanalgesia involves the use of a probe to apply extreme cold (approximately -70◦C) to induce reversible axonal injury and Wallerian degeneration to produce a temporary conduction block that is sustained until regeneration of the axon and sensation is restored, typically weeks to months later.

06

What researchers measure

Primary outcomes

  1. Primary Outcome Measure

    CryoNerve Block procedural complications

    Time frame: 30 days

07

Study locations

9 of 9 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2025 (actual). Primary completion is estimated for Apr 2035, 120 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 19, 2025
First posted
Apr 3, 2025
StartActual
Apr 1, 2025
Primary completionEst.
Apr 2035
CompletionEst.
Apr 2035
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
3 sites added
Show 3 added (3 United States)
  • Jacksonville Center for Clinical Research · Jacksonville, United States
  • Duke University Health System · Durham, United States
  • OhioHealth Research Institute · Columbus, United States
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    3 sites added
    Show 3 added (3 United States)
    • Jacksonville Center for Clinical Research · Jacksonville, United States
    • Duke University Health System · Durham, United States
    • OhioHealth Research Institute · Columbus, United States

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06908538
Lead sponsor
AtriCure, Inc.
Responsible party
Sponsor
First posted
Apr 3, 2025
Start date
Apr 1, 2025
Primary completion
Apr 2035 (estimated)
Completion
Apr 2035 (estimated)
Last update
Nov 6, 2026

Study contacts

Senior Registry Specialist
Contact
CryoNB-registry@atricure.com
1 (866) 349-2342

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion